Connection

Bruce Hollis to Aged

Back to Details
This is a "connection" page, showing publications Bruce Hollis has written about Aged.
Bruce Hollis
Connection Strength
0.527
Aged
  1. Vitamin D efficacy and safety. Arch Intern Med. 2011 Feb 14; 171(3):266; author reply 267.
    View in: PubMed
    Score: 0.031
  2. Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States. J Am Coll Nutr. 2009 Dec; 28(6):678-86.
    View in: PubMed
    Score: 0.028
  3. Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem. 2000 Oct; 46(10):1657-61.
    View in: PubMed
    Score: 0.015
  4. Vitamin D Synthesis Following a Single Bout of Sun Exposure in Older and Younger Men and Women. Nutrients. 2020 Jul 27; 12(8).
    View in: PubMed
    Score: 0.015
  5. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab. 1999 Aug; 84(8):2729-30.
    View in: PubMed
    Score: 0.014
  6. Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. Aust N Z J Med. 1999 Aug; 29(4):512-6.
    View in: PubMed
    Score: 0.014
  7. Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2019 08; 28(8):1379-1387.
    View in: PubMed
    Score: 0.014
  8. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial. JAMA. 2019 04 09; 321(14):1370-1379.
    View in: PubMed
    Score: 0.014
  9. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations =60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort. PLoS One. 2018; 13(6):e0199265.
    View in: PubMed
    Score: 0.013
  10. Vitamin D supplementation and body fat mass: a systematic review and meta-analysis. Eur J Clin Nutr. 2018 10; 72(10):1345-1357.
    View in: PubMed
    Score: 0.013
  11. Systems analysis of the prostate transcriptome in African-American men compared with European-American men. Pharmacogenomics. 2016 07; 17(10):1129-1143.
    View in: PubMed
    Score: 0.011
  12. Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months. Sci Rep. 2015 Jun 22; 5:10411.
    View in: PubMed
    Score: 0.010
  13. Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D. Am J Med. 2014 Aug; 127(8):772-8.
    View in: PubMed
    Score: 0.010
  14. Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr. 2014 Mar; 99(3):587-98.
    View in: PubMed
    Score: 0.009
  15. Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial. Atherosclerosis. 2013 Jun; 228(2):502-7.
    View in: PubMed
    Score: 0.009
  16. Vitamin D3 supplementation (4000 IU/d for 1 y) eliminates differences in circulating 25-hydroxyvitamin D between African American and white men. Am J Clin Nutr. 2012 Aug; 96(2):332-6.
    View in: PubMed
    Score: 0.008
  17. Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung Cancer. 2012 Aug; 77(2):265-71.
    View in: PubMed
    Score: 0.008
  18. Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab. 2012 Jul; 97(7):2315-24.
    View in: PubMed
    Score: 0.008
  19. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012 May 02; 104(9):690-9.
    View in: PubMed
    Score: 0.008
  20. Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. PLoS One. 2011; 6(12):e28520.
    View in: PubMed
    Score: 0.008
  21. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D Levels among African Americans. PLoS One. 2011; 6(12):e28623.
    View in: PubMed
    Score: 0.008
  22. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 2011 Oct; 5(6):538-68.
    View in: PubMed
    Score: 0.008
  23. Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr. 2011 Aug; 106(3):339-44.
    View in: PubMed
    Score: 0.008
  24. Cord blood vitamin D status impacts innate immune responses. J Clin Endocrinol Metab. 2011 Jun; 96(6):1835-43.
    View in: PubMed
    Score: 0.008
  25. Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011 Apr 06; 6(4):e18625.
    View in: PubMed
    Score: 0.008
  26. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila). 2011 May; 4(5):735-43.
    View in: PubMed
    Score: 0.008
  27. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol. 2011 Apr 20; 29(12):1599-606.
    View in: PubMed
    Score: 0.008
  28. The response of elderly veterans to daily vitamin D3 supplementation of 2,000 IU: a pilot efficacy study. J Am Geriatr Soc. 2011 Feb; 59(2):286-90.
    View in: PubMed
    Score: 0.008
  29. Is the recommended daily allowance for vitamin D too low for the homebound elderly? J Am Geriatr Soc. 1991 Feb; 39(2):137-41.
    View in: PubMed
    Score: 0.008
  30. Cutaneous formation of vitamin D in psoriasis. Arch Dermatol. 1990 Aug; 126(8):1107-8.
    View in: PubMed
    Score: 0.007
  31. The relationship of 1,25-dihydroxyvitamin D and radial bone mass. Bone Miner. 1990 Aug; 10(2):139-48.
    View in: PubMed
    Score: 0.007
  32. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010 Sep; 9(11):709-15.
    View in: PubMed
    Score: 0.007
  33. Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose. J Clin Endocrinol Metab. 2010 Mar; 95(3):1279-87.
    View in: PubMed
    Score: 0.007
  34. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009 Sep 15; 101(6):916-23.
    View in: PubMed
    Score: 0.007
  35. Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int. 2009 Oct; 104(7):909-14.
    View in: PubMed
    Score: 0.007
  36. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer. 2009 Feb 15; 124(4):979-86.
    View in: PubMed
    Score: 0.007
  37. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009 Feb 15; 69(4):1439-47.
    View in: PubMed
    Score: 0.007
  38. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol. 2008 Dec 01; 26(34):5596-602.
    View in: PubMed
    Score: 0.007
  39. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008 Jun 20; 26(18):2984-91.
    View in: PubMed
    Score: 0.006
  40. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008 Jun 09; 168(11):1174-80.
    View in: PubMed
    Score: 0.006
  41. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst. 2008 Jun 04; 100(11):796-804.
    View in: PubMed
    Score: 0.006
  42. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):889-94.
    View in: PubMed
    Score: 0.006
  43. Vitamin D insufficiency in southern Arizona. Am J Clin Nutr. 2008 Mar; 87(3):608-13.
    View in: PubMed
    Score: 0.006
  44. Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control. 2008 Jun; 19(5):527-35.
    View in: PubMed
    Score: 0.006
  45. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007 Jul 18; 99(14):1120-9.
    View in: PubMed
    Score: 0.006
  46. Vitamin D status of patients admitted to a hospital rehabilitation unit: relationship to function and progress. Am J Phys Med Rehabil. 2007 Jun; 86(6):435-45.
    View in: PubMed
    Score: 0.006
  47. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007 Feb 10; 25(5):479-85.
    View in: PubMed
    Score: 0.006
  48. Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J Steroid Biochem Mol Biol. 2007 Mar; 103(3-5):752-6.
    View in: PubMed
    Score: 0.006
  49. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006 Apr 05; 98(7):451-9.
    View in: PubMed
    Score: 0.005
  50. Bioavailability of vitamin D from fortified process cheese and effects on vitamin D status in the elderly. J Dairy Sci. 2005 Jul; 88(7):2295-301.
    View in: PubMed
    Score: 0.005
  51. Vitamin d deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab. 2005 Mar; 90(3):1557-62.
    View in: PubMed
    Score: 0.005
  52. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004 Sep; 13(9):1502-8.
    View in: PubMed
    Score: 0.005
  53. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):533-7.
    View in: PubMed
    Score: 0.005
  54. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):546-52.
    View in: PubMed
    Score: 0.005
  55. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004 Apr; 15(3):255-65.
    View in: PubMed
    Score: 0.005
  56. Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies. Invest New Drugs. 2003 Nov; 21(4):445-52.
    View in: PubMed
    Score: 0.005
  57. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002 Jul; 76(1):187-92.
    View in: PubMed
    Score: 0.004
  58. Vitamin D receptor genotype and the risk of bone fractures in women. Epidemiology. 1998 Sep; 9(5):535-9.
    View in: PubMed
    Score: 0.003
  59. An audit of low dose triple therapy for eradication of Helicobacter pylori. N Z Med J. 1996 Aug 09; 109(1027):290-2.
    View in: PubMed
    Score: 0.003
  60. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1996 Feb; 5(2):121-6.
    View in: PubMed
    Score: 0.003
  61. Vitamin D deficiency in homebound elderly persons. JAMA. 1995 Dec 06; 274(21):1683-6.
    View in: PubMed
    Score: 0.003
  62. Functional improvement with vitamin D replenishment in a cohort of frail, vitamin D-deficient older people. J Am Geriatr Soc. 1995 Nov; 43(11):1269-71.
    View in: PubMed
    Score: 0.003
  63. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States) Cancer Causes Control. 1995 May; 6(3):235-9.
    View in: PubMed
    Score: 0.003
  64. Biochemical parameters associated with low bone density in healthy men and women. J Bone Miner Res. 1992 Oct; 7(10):1123-30.
    View in: PubMed
    Score: 0.002
  65. Radial bone mineral density in pre- and perimenopausal women: a prospective study of rates and risk factors for loss. J Bone Miner Res. 1992 Jun; 7(6):647-57.
    View in: PubMed
    Score: 0.002
  66. Ten weeks of intermittent hypocalcemic stimulation does not produce functional parathyroid hyperplasia. Am J Med Sci. 1991 Sep; 302(3):138-41.
    View in: PubMed
    Score: 0.002
  67. Relationship between 1,25-dihydroxyvitamin D and blood pressure in a geographically defined population. Am J Clin Nutr. 1988 Oct; 48(4):1053-6.
    View in: PubMed
    Score: 0.002
  68. Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy. Calcif Tissue Int. 1988 Jan; 42(1):18-22.
    View in: PubMed
    Score: 0.002
  69. Parameters related to 25-OH-D levels in a population-based study of women. Am J Clin Nutr. 1986 Apr; 43(4):621-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.